tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Chris Schott, 225 are a BUY (67.16%), 97 are a HOLD (28.96%), 13 are a SELL (3.88%).
Analyst Chris Schott, currently employed at JPMORGAN, carries an average stock price target met ratio of 52.77% that have a potential upside of 27.81% achieved within 348 days.
Chris Schott’s has documented 651 price targets and ratings displayed on 31 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AMRX, Amneal Pharmaceuticals.
Analyst best performing recommendations are on EQRX (EQRX).
The best stock recommendation documented was for EQRX (EQRX) at 8/16/2022. The price target of $5.5 was fulfilled within 3 days with a profit of $0.67 (13.87%) receiving and performance score of 46.24.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-Feb-2026
$325
$39.36 (13.78%)
$300
Buy Since 05-Feb-2020
$288
$2.36 (0.83%)
$288
16 days ago
(09-Oct-2026)
45/45 (100%)
$11.53 (4.17%)
407
Hold Since 07-Jan-2026
$275
$-10.64 (-3.72%)
$260
16 days ago
(09-Oct-2026)
5/5 (100%)
$-1.47 (-0.53%)
76
Buy Since 16-Oct-2020
$300
$14.36 (5.03%)
$280
17 days ago
(08-Oct-2026)
20/21 (95.24%)
$27.58 (10.12%)
441
Buy Since 16-Nov-2023
$290
$4.36 (1.53%)
$285
17 days ago
(08-Oct-2026)
31/32 (96.88%)
$17.58 (6.45%)
251
Which stock is Chris Schott most bullish on?
Which stock is Chris Schott most reserved on?
What Year was the first public recommendation made by Chris Schott?
